Compare AMPH & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMPH | HAFC |
|---|---|---|
| Founded | 1996 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.8M | 821.2M |
| IPO Year | 2005 | 2000 |
| Metric | AMPH | HAFC |
|---|---|---|
| Price | $19.31 | $30.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | $28.38 | ★ $32.17 |
| AVG Volume (30 Days) | ★ 371.8K | 228.0K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | N/A | ★ 22.44 |
| EPS | 0.14 | ★ 2.51 |
| Revenue | ★ $719,887,000.00 | $270,165,000.00 |
| Revenue This Year | $6.90 | $18.65 |
| Revenue Next Year | $4.64 | $7.28 |
| P/E Ratio | ★ $11.87 | $12.12 |
| Revenue Growth | N/A | ★ 15.28 |
| 52 Week Low | $17.03 | $21.84 |
| 52 Week High | $31.26 | $31.33 |
| Indicator | AMPH | HAFC |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 63.93 |
| Support Level | $18.92 | $26.13 |
| Resistance Level | $20.08 | $31.33 |
| Average True Range (ATR) | 0.80 | 0.74 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 14.80 | 75.79 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.